ロード中...
Prevalence and Determinants of End of Life Chemotherapy Use in Patients with Metastatic Breast Cancer
BACKGROUND: Cessation of chemotherapy in the last few weeks of life could be an important quality of care benchmark. Proportion of metastatic breast cancer patients who receive end of life chemotherapy is not well described. We aimed to determine the prevalence and determinants of end of life chemot...
保存先:
| 出版年: | Breast J |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5675818/ https://ncbi.nlm.nih.gov/pubmed/28845536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tbj.12905 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|